AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
Dec 29, 2014
30016_dirs_2014-12-29_93524f87-e1e0-45b1-8487-c567b300649a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-12-23
Reporting Person: MAZELSKY JAY (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-23 | Common Stock | M | 1000 | $95.06 | Acquired | 3366 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-23 | Incentive Stock Option (right to buy) | $95.06 | M | 1000 | Disposed | 2019-08-31 | Common Stock (1000) | Direct |
Footnotes
F1: Grant of options to buy shares of common stock that became exercisable as to 51 shares on 09/01/2013 and 1,051 shares on 09/01/2014. The remaining options will become exercisable over the course of the next three grant date anniversaries on 09/01/2015, 09/01/2016 and 09/01/2017.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26